STUDY DESIGN: This is a secondary analysis of a prospective, multicenter, observational study that included women with prior CD (MFMU Cesarean Registry). Two groups of patients from the registry were studied: patients with MAP and patients with placenta previa regardless of MAP (PP). The exposure of interest was the number of prior CD: 2 CD compared to 1 CD. The primary outcome was PTD <34 weeks. Secondary outcomes included transfusion of blood products, preterm labor requiring hospitalization/tocolysis, NICU admission, and a composite of maternal and neonatal complications. Balance of maternal demographics in the two groups was assessed using two sample t-tests and chi-square tests, and potential confounders were included in multivariable logistic regression models. Backward selection was used to identify parsimonious models. RESULTS: The MAP analysis included 194 women, 97 (50%) of whom had 1 prior CD and 97 (50%) of whom had 2 prior CD. There was no increased risk of PTD <34 weeks in women with 2 prior CD in the setting of MAP (23.7% vs. 29.9%, p¼0.27). Only need for plasma transfusion was associated with 2 prior CD (29.9% vs. 17.5%, p¼0.04) ( Table 1 ). There were 776 women with PP, 667 (86%) with 1 prior CD and 109 (14%) with 2 prior CD. Similarly, there was no increased risk of PTD <34 weeks with 2 CD in the setting of PP (27.5% vs. 22.6%, p¼0.08). However, it was associated with a higher odds of need for transfusion and the maternal composite outcome (Table 2) . CONCLUSION: Women with MAP or PP who have had 2 prior CD did not appear to have a higher risk of complications or PTD<34 weeks. Those with 2 prior CD may have a higher risk of maternal complications including need for transfusion products that may be independent of timing of delivery.
309 The impact of a birth plan on maternal and neonatal delivery outcomes 
OBJECTIVE:
To evaluate the impact of a written birth plan on maternal and neonatal outcomes. STUDY DESIGN: This is a prospective, non-randomized controlled trial of low-risk women with and without a written birth plan who presented to labor and delivery at term. Each woman with a birth plan was matched sequentially with the next woman of similar age, body mass index, parity and spontaneous vs. induced labor pattern, but without a birth plan. Indices of maternal and neonatal outcome were then compared. RESULTS: Women in each group were demographically similar. There were no differences in the length of any phase or stage of labor. Women with a birth plan were 25% more likely to undergo cesarean delivery, although this difference did not reach statistical significance (24% vs. 18%, p ¼ 0.46 ) However, a longer birth plan was associated with a significantly higher rate of cesarean delivery (p ¼ 0.039.) Neonates of women with a birth plan had a statistically significant increase in the rate of meconium passage (26% vs. 10%, p ¼ 0.04), significantly greater arterial and venous base deficit (arterial -5.4 vs. -3.6, p ¼ 0.01), and significantly lower umbilical artery and vein pH values (arterial 7.23 vs. 7.28, p ¼ 0.004).
CONCLUSION: We could demonstrate no medical benefit to a written birth plan. However, a birth plan was associated with a significant increase in neonatal indices of intrapartum metabolic acidemia. A longer birth plan was also associated with a significantly higher rate of cesarean delivery. Maternal actions that modify standard care processes have the potential for harm, without medical benefit. Patients and providers should understand the potential for such effects of maternal birth plans on labor and neonatal outcomes. 
